Marex Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Marex Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$458K	Buy	+3,588	New	+$448K	﹤0.01%	649
2025 Q4	–	Sell	-3,294	Closed	-$378K	–	1160
2025 Q3	$330K	Sell	3,294 -4,574	-58%	-$412K	﹤0.01%	601
2025 Q2	$652K	Buy	7,868 +3,058	+64%	+$244K	0.01%	346
2025 Q1	$390K	Buy	+4,810	New	+$430K	0.01%	393
2024 Q4	–	Sell	-23,869	Closed	-$2.36M	–	824
2024 Q3	$2.36M	Buy	+23,869	New	+$2.35M	0.05%	134
2024 Q1	–	Sell	-4,574	Closed	-$408K	–	683
2023 Q4	$408K	Sell	4,574 -10,323	-69%	-$767K	0.02%	336
2023 Q3	$1.09M	Buy	14,897 +11,255	+309%	+$899K	0.15%	71
2023 Q2	$303K	Buy	+3,642	New	+$305K	0.05%	173

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Marex Group's XBI Position: Q1 2026 in Review

Marex Group opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 3,588 shares worth $458K. The stake represents ﹤0.01% of the portfolio and ranks #649 among its holdings. This is a return to the name: Marex Group previously reported a position in XBI as recently as Q3 2025.

Marex Group first reported a position in XBI in Q2 2023 and has held it in 8 quarters since. The position peaked at $2.36M in Q3 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Marex Group held 3,588 shares of State Street SPDR S&P Biotech ETF worth $458K as of Q1 2026.
State Street SPDR S&P Biotech ETF was a new Marex Group position in Q1 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Marex Group's portfolio in Q1 2026, its #649 holding.
Marex Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2023 and has held it in 8 quarters since.
Marex Group's State Street SPDR S&P Biotech ETF position peaked at $2.36M in Q3 2024.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.